Please use this identifier to cite or link to this item: http://localhost:8080/xmlui/handle/123456789/7971
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSupadmi, Woro-
dc.contributor.authorFitriana, Elinda-
dc.contributor.authorMuhlis, Muhammad-
dc.date.accessioned2024-11-15T03:11:19Z-
dc.date.available2024-11-15T03:11:19Z-
dc.date.issued2024-03-
dc.identifier.issn2088 4559-
dc.identifier.urihttp://localhost:8080/xmlui/handle/123456789/7971-
dc.description.abstractPatients with chronic renal failure must undergo lifelong treatment. The condition raises treatmentrelated responsibilities and may affect their treatment adhesion. The aim of this study was to determine the correlation between the burden of medication and the level of medication adherence among chronic kidney failure patients at Sleman Regional Hospital in Yogyakarta. This study took the form of observational study with a cross-sectional design. Data were collected using LMQ (Living with Medicine Questionnaire) and Visual Analog Sacle (VAS) overall burden to determine the burden and MARS (Medication Adherence Rating Scale) to determine medication adherence level. The samples in this study were 60 patients from all patients undergoing hemodialysis who met the inclusion criteria. Sampling was taken using a consecutive sampling technique with inclusion criteria of patients willing to complete the questionnaire and patients diagnosed with chronic renal failure aged ≥18 years. To determine the relationship between medication burden and medication adherence, data was examined using the Spearman test. The results of this study showed that 40 patients (66.7%) had moderate medication burden and 50 patients (83%) had moderate medication adherence. There was a significant correlation between the LMQ score and MARS (correlation-coefficient = 0.581, p=0.000) and a significant correlation between the VAS score and MARS (correlation-coefficient= 0.651, p=0.000). Thus, it can be concluded that there is a positive relationship between treatment burden and the level of treatment compliance, where the higher the burden, the higher the level of compliance in chronic kidney failure patients.en_US
dc.language.isoen_USen_US
dc.publisherPharmacianaen_US
dc.subjectadherenceen_US
dc.subjectchronic renal failureen_US
dc.subjectmedication-related burdenen_US
dc.titleMedication-related burden of chronic renal failure patients at regional general hospital Sleman Yogyakartaen_US
dc.typeArticleen_US
Appears in Collections:VOL 14 NO 1 2024

Files in This Item:
File Description SizeFormat 
5.pdf318.52 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.